Experiment I Sample Clauses

Experiment I. Retrieving a Wide Array of Performance Artifacts‌ Experiment I focuses on generating many performance artifacts. This takes its toll on the high-level model quality which is simple, and moreover limits perfor- xxxxx evaluation, viz., primarily discrete-event simulations are performed. For the sake of efficiency, the running example as introduced in Sect. 3 is reused.
Sample 1Sample 2See All (4)
AutoNDA by SimpleDocs
Experiment I. Elapsed time and peak memory usage of Algorithm AvoidedWords using synthetic DNA (σ = 4) and proteins (σ = 20) data of length 1MB for variable ρ. DNA Proteins 1200 1000 800 Time [s] 600 400 200 0 2e+07 4e+07 6e+07 8e+07 1e+08 1.2e+08 Length n [bp]
Sample 1
Experiment I. The purpose of this study was to evaluate the efficacy of bio-fungicides applied at planting in reducing the incidence of restricted tip rot, unrestricted end rot and soft rots in postharvest and improve pack out efficiency. On-farm (BHF farms, Pontotoc, MS) and on-station (Pontotoc Ridge-Flatwoods branch, Pontotoc, MS) field trials were conducted with ‘Xxxxxxxxxx B14’ sweetpotato over 2 years. Bio-fungicides used were Serenade® Soil (AgraQuest, Davis, CA), Actinovate® SP (Natural Industries, Inc., Houston, TX) and RootShield® (BioWorks, Xxxxxx, NY). The application method was dipping the transplants in bio-fungicide solution at recommended rates. Prior to harvest (1 week), half of the plots were sprayed with ethephon to promote restricted tip rot incidence and the other half was devined mechanically. Two months after harvest, 2 bushels of storage roots from the station studies were evaluated for rots. In the case of on-farm studies, 2 bins from each treatment were run through the packing line and rotten roots were separated from marketable roots and pack out efficiency was determined. Results indicate that the reduction of unrestricted end rots and soft rots were inconsistent with the bio- fungicides tested. Soil moisture prior to harvest appeared to have been involved in unrestricted end rot incidence and the reduction by the bio-fungicides: high soil moisture increased incidence, but at a reduced level in the presence of bio-fungicides. There were no differences in unrestricted end rot and soft rot between bio-fungicides and untreated control when soil moisture was reduced at harvest. Preharvest application of ethephon enhanced the incidence of restricted tip rot in sweetpotato which is in agreement with previous studies. Bio-fungicides, however, were unable to reduce the incidence of restricted tip rot in comparison with the ethephon treated control. Roots from the on-farm study (in partnership with Xxxxx Xxxxxxxx at BHF farms) were evaluated 3 months after harvest. Storage roots were separated in a commercial packinghouse (in partnership with Xxxxxxxxx farms) following commercial standards. There were no differences in rot incidence, pack out proportion, and US no.1 grade roots among the treatments. This experiment was conducted in 2013 only, but results are in agreement with the other studies.
Sample 1

Related to Experiment I

  • Research Support opioid abatement research that may include, but is not limited to, the following:

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

  • Screening 3.13.1 Refuse containers located outside the building shall be fully screened from adjacent properties and from streets by means of opaque fencing or masonry walls with suitable landscaping.

  • Trials The Ship shall run the following test and trials:

  • Development Phase contractual phase initiated with the approval of ANP for the Development Plan and which is extended during the Production Phase while investments in xxxxx, equipment, and facilities for the Production of Oil and Gas according to the Best Practices of the Oil Industry are required.

  • Technology Research Analyst Job# 1810 General Characteristics Maintains a strong understanding of the enterprise’s IT systems and architectures. Assists in the analysis of the requirements for the enterprise and applying emerging technologies to support long-term business objectives. Responsible for researching, collecting, and disseminating information on emerging technologies and key learnings throughout the enterprise. Researches and recommends changes to foundation architecture. Supports research projects to identify and evaluate emerging technologies. Interfaces with users and staff to evaluate possible implementation of the new technology in the enterprise, consistent with the goal of improving existing systems and technologies and in meeting the needs of the business. Analyzes and researches process of deployment and assists in this process.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • For Product Development Projects and Project Demonstrations  Published documents, including date, title, and periodical name.  Estimated or actual energy and cost savings, and estimated statewide energy savings once market potential has been realized. Identify all assumptions used in the estimates.  Greenhouse gas and criteria emissions reductions.  Other non-energy benefits such as reliability, public safety, lower operational cost, environmental improvement, indoor environmental quality, and societal benefits.  Data on potential job creation, market potential, economic development, and increased state revenue as a result of the project.  A discussion of project product downloads from websites, and publications in technical journals.  A comparison of project expectations and performance. Discuss whether the goals and objectives of the Agreement have been met and what improvements are needed, if any.

Time is Money Join Law Insider Premium to draft better contracts faster.